Previous Article | Next Article ![]()
Clinical and Vaccine Immunology, June 2009, p. 811-815, Vol. 16, No. 6
1071-412X/09/$08.00+0 doi:10.1128/CVI.00121-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Patologia Clinica,1 Sezione di Patologia Generale, Dipartimento di Biopatologia e Metodologie Biomediche,2 Dipartimento di Medicina Clinica e delle Patologie Emergenti, University of Palermo, Palermo, Italy,3 Servizio di Patologia Clinica, V. Cervello Hospital, Palermo, Italy4
Received 11 March 2009/ Returned for modification 7 April 2009/ Accepted 15 April 2009
The acute phase of Mediterranean spotted fever (MSF) is characterized by dramatic changes in cytokine production patterns, clearly indicating their role in the immunomodulation of the response against the microorganism, and the differences in cytokine production seem to influence the extent and severity of the disease. In this study, the single nucleotide polymorphisms (SNPs) of tumor necrosis factor alpha (TNF-
) –308G/A (rs1800629) and interleukin-10 (IL-10) –1087G/A (rs1800896), –824C/T (rs1800871), and –597C/A (rs1800872) and the gamma interferon (IFN-
) T/A SNP at position +874 (rs2430561) were typed in 80 Sicilian patients affected by MSF and in 288 control subjects matched for age, gender, and geographic origin. No significant differences in TNF-
–308G/A genotype frequencies were observed. The +874TT genotype, associated with an increased production of IFN-
, was found to be significantly less frequent in MSF patients than in the control group (odds ratio [OR], 0.18; 95% confidence interval [95% CI], 0.06 to 0.51; P corrected for the number of genotypes [Pc], 0.0021). In addition, when evaluating the IFN-
and IL-10 genotype interaction, a significant increase of +874AA/–597CA (OR, 5.31; 95% CI, 2.37 to 11.88; Pc, 0.0027) combined genotypes was observed. In conclusion, our data strongly suggest that finely genetically tuned cytokine production may play a crucial role in the regulation of the immune response against rickettsial infection, therefore influencing the disease outcomes, ranging from nonapparent or subclinical condition to overt or fatal disease.
Published ahead of print on 22 April 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»